ArticleBMC gastroenterology2026
Global and regional disparities in the burden of disease and risk factors between pancreatitis and pancreatic cancer: a systematic analysis for the global burden of disease study.
Article in BMC gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- ENPP1 as a contributor to chronic pancreatitis-related PDAC.Nature reviews. Gastroenterology & hepatology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDespite their substantial global health impact, there has been no systematic and comprehensive evaluation of the epidemiological patterns and risk factors of pancreatitis and pancreatic cancer worldwide. This study aimed to quantify and compare epidemic indicators and their changing trends by sex, age group, and socio-demographic status from 1990 to 2019.
methodsWe extracted data on pancreatitis and pancreatic cancer from the 2019 the Global Burden of Disease (GBD) study for 204 countries and territories from 1990 to 2019. The data of incidence, prevalence, morbidity, mortality, burden and age-standardized rates of pancreatitis and pancreatic cancer were collected. Risk factors contributing to the burden of pancreatitis and pancreatic cancer were estimated using the comparative risk assessment framework.
resultsThe age-standardized incidence, prevalence, and Disability Adjusted Life Years (DALYs) per 100,000 person-years were 34.8, 29.3, and 44.4 for pancreatitis, compared with 6.4, 5.1, and 6.5 for pancreatic cancer, respectively. The incidence and prevalence of both pancreatitis and pancreatic cancer were higher in countries with a high Socio-demographic Index (SDI). For both conditions, incidence, prevalence, mortality, and DALYs were higher in men than in women. According to multivariate analysis, alcohol consumption (OR = 1.24, p = 0.01), body mass index (OR = 2.37, p = 0.02), total cholesterol (OR = 1.66, p < 0.001), and hypertension (OR = 1.26, p = 0.013) were significantly associated with prevalence of pancreatitis. For pancreatic cancer, alcohol consumption (OR = 1.58, p = 0.001), total cholesterol (OR = 1.97, p < 0.001), and hypertension (OR = 1.35, p = 0.019) were significantly associated with prevalence.
conclusionsPancreatitis exhibited a greater incidence, prevalence, and DALY burden, whereas pancreatic cancer carried a disproportionately higher mortality burden. Modifiable risk factors – including alcohol consumption, smoking, BMI, obesity, hypertension, and hypercholesterolemia were strongly associated with both conditions, underscoring the need for targeted prevention strategies and improved disease management to reduce the global burden.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.